The Report Guru

 According to research report the pacemakers market is projected to reach USD 4.9 billion by 2023 from USD 4.4 billion in 2018, at a CAGR of 2.0% during the forecast period. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=243344814 A pacemaker is a medical device used when the heart is unable to produce electrical impulses naturally. When the heart’s natural pacemaker is defective or when the electrical pathways of the heart are blocked, it can cause irregular heartbeats, as known as arrhythmias. A pacemaker uses electrical pulses to prompt the heart to beat at a normal rate to treat arrhythmias. Recent Developments: • In November 2017, Medtronic received FDA approval and launched the Azure pacemaker with BlueSync technology in the US market • In February 2017, Medtronic received CE Mark certification for its Next Generation Cardiac Resynchronization Therapy-Pacemakers • In February 2017, Abbott Laboratories received FDA approval for the Assurity

 According to the new market research report ECG Market is expected to reach USD 10.3 billion by 2024 from USD 7.5 billion in 2019, at a CAGR of 6.4% during the forecast period. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=173 Factors such as the rising incidence of lifestyle & cardiovascular diseases and increasing geriatric population are expected to propel the growth of the diagnostic electrocardiograph market. Asia Pacific diagnostic ECG market is expected to grow at the highest CAGR during the forecast period On the basis of region, the diagnostic ECG market is segmented into North America, Europe, Asia Pacific, and RoW. The Asia Pacific is expected to grow at the highest CAGR during the forecast period. Factors such as growth in the geriatric population, growing incidence of chronic diseases, rising healthcare spending, healthcare reforms for infrastructural development, growing demand for advanced technologies, and less stringent

  According to research report the global competent cells market is projected to reach USD 2.22 billion by 2022 from USD 1.37 billion in 2017, at a CAGR of 10.2%. Download PDF Brochure: https://www.marketsandmarkets.com/requestsampleNew.asp?id=265815900 Advancements in molecular cloning research due to the emergence of new technologies and increasing commercial demand for molecular cloned products and recombinant proteins are the major factors driving the growth of the competent cells market. North America to dominate the competent cells market in 2017 By region, the global competent cells market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). In 2017, North America is expected to account for the largest share of the market. This can be attributed to the increasing intensity of research due to technological advancement and increasing commercial needs for genomic and protein expressed products, in North American countries. By applicatio

  According to research report the Medical Device Contract Manufacturing Market is expected to reach USD 91.3 billion by 2024 from an estimated USD 55.0 billion in 2019, at a CAGR of 10.6%. Newer and advanced technologies necessitate the incorporation of advanced manufacturing methods, which result in increased overall costs. Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=170622851 Factors such as increasing automation in the manufacturing of medical devices and advanced technologies integrating electronics and medical devices are expected to drive the growth of the medical device contract manufacturing market. Medical device contract manufacturers specialize in a certain process or task and offer expertise from the frequent practice of their manufacturing. Service or services for customers, clients, and inventors of medical devices include product concept and development, process validation and verification, production, or highly special

  Factors such as the growing industrial applications of hyperspectral imaging and increasing funding and investments are driving the growth of the global hyperspectral imaging systems market . According to the new market research report Hyperspectral Imaging Systems Market is projected to reach USD 30.0 billion by 2025 from USD 12.4 billion in 2020, at a CAGR of 19.3%. Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=246979343 The prominent players in this hyperspectral imaging systems market include Headwall Photonics, Inc. (US), Specim, Spectral Imaging Ltd. (Finland), Corning Incorporated (US), Norsk Elektro Optikk AS (Norway), Raytheon Company (US), Resonon Inc. (US), Telops (Canada), Surface Optics Corporation (US), Applied Spectral Imaging Ltd. (US), ChemImage Corporation (US), Cubert GmbH (Germany), BaySpec, Inc. (US). Players in this market focused on product launches, partnerships, agreements, collaborations, and acquisitions to dev

 According to research report the medical image management system market is projected to reach USD 4.40 billion in 2023 from USD 3.04 billion in 2018 at a CAGR of 7.7% during the forecast period. Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=240573338 Technological advancements in diagnostic imaging modalities and image management software, growing investments in the medical imaging market, government initiatives to encourage EMR adoption, increasing usage of imaging equipment, growing adoption of image management systems by small hospitals and imaging centers, and rapidly growing big data in healthcare are factors driving the growth of the medical image management system market. On the other hand, budgetary constraints and longer product lifecycle of VNA may limit market growth to a certain extent during the forecast period. North America to dominate the market in 2018 In 2018, North America is expected to command the largest share

  According to the new market research report In Vitro Toxicity Testing Market is expected to reach USD 14.9 billion by 2025 from an estimated USD 9.1 billion in 2020, at a CAGR of 10.3%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=209577065 The major factors driving the growth of this in vitro toxicity testing market are the opposition to animal testing, technological advancements, and increasing R&D expenditure to detect toxicity at an early stage during drug development are the primary growth drivers for this market. Asia Pacific is estimated to be the fastest-growing market for in vitro toxicology testing during the forecast period The APAC in vitro toxicology testing market is projected to register the highest growth during the forecast period. Factors such as emergence of CROs for outsourcing toxicology-related research projects, opposition to animal testing resulting in the use of alternate methods, increasing pharmaceutical drug

  According to research report the clinical alarm management market is expected to reach $1,724 million by 2023 from an estimated $457 million in 2018, at a CAGR of 30.4% during the forecast period. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=69939577 Growth in the clinical alarm management market can be attributed to the increasing alarm fatigue, high prevalence of chronic diseases, growth in the geriatric population, need for cost-containment in healthcare delivery, and rising prominence and usage of big data and mHealth tools. North America is estimated to account for the largest share of the clinical alarm software market in 2018. The large share of this region can be attributed to the increasing cases of alarm fatigue and initiatives by government bodies to curtail the effects of alarm fatigue and the increasing need for integrated healthcare IT systems to ensure reliability, efficient maintenance of data, data integrity, and timely

  According to the new market research report Antimicrobial Susceptibility Testing Market by Product (Manual, Automated Susceptibility Testing System), Type (Antibacterial, Antifungal), Application (Clinical Diagnostics), Method (ETEST, Disk Diffusion), End-User - Global Forecasts to 2025, published by MarketsandMarkets™, the Antimicrobial Susceptibility Testing Market is projected to reach USD 4.2 billion by 2025 from USD 3.2 billion in 2020, at a CAGR of 5.5% during the forecast period. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=206359984 The growth of the antibacterial susceptibility testing systems market is mainly driven by the growing number of hospitals across major markets, increasing awareness about diagnosis and the treatment of hospital-acquired infections coupled with the increasing adoption of rapid AST methods. Moreover, rising R&D investments by the key players operating in the market to develop genetics and genoty

  According to the market research report Stable Isotope Labeled Compounds Market is projected to grow at a CAGR of 3.0% during the forecast period to reach USD 312 million by 2024 from USD 269 million in 2019. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=53034199 The Factors such as the increase in research activities in the pharmaceutical and biotechnology sector, rising proteomics research, and the rising prevalence of cancer. North America to dominate the Stable Isotope Labeling Market during the forecast period In 2019, North America dominated the Stable Isotope Labeled Compounds Market, followed by Europe. The major factors driving the growth of the Stable Isotope Labeling Market include the growth of the pharmaceutical and biopharmaceutical industry, the large nuclear industry in the US, the growth of the Canadian pharmaceutical industry, and the availability of funding in North American countries. The H-2 labeled compounds segment a

 According to research report the global structural heart devices market is projected to reach USD 15.08 billion by 2023 from USD 9.28 billion in 2018, at a CAGR of 10.2%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=161123753 Growth in the structural heart devices market is mainly driven by factors such as the rising prevalence of structural heart diseases, regulatory approvals for new and advanced structural heart devices, favorable reimbursement scenario for structural heart procedures & devices, and increasing awareness about structural heart diseases. North America to dominate the structural heart market in 2018 North America is expected to account for the largest share of the structural heart devices market in 2018, followed by Europe. The large share of North America in the global market is attributed to factors such as the rising prevalence of structural heart diseases, favorable reimbursement scenario for structural heart proced

  According to the new market research report the Spinal Surgery Devices Market is projected to reach USD 13.8 billion by 2025 from USD 10.3 billion in 2019, at a CAGR of 5.0%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=712 The advancements in spine surgeries technologies, such as the development of safer, more effective, advanced, simple, and easy-to-use spinal implants and devices; the increasing incidence of spinal disorders; and the launch of advanced bone grafting products are some of the key factors driving the growth of the Spinal Surgery Devices Market. North America dominates the Spinal Implants Devices Market. The Spinal Surgery Devices Market is segmented into five regional segments, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The large share of the North American market can be attributed to its highly developed healthcare infrastructure and reimbursement systems and high pa

 The advantages of minimally invasive surgeries over traditional open surgeries and the increasing number of minimally invasive surgical procedures across the globe are the key factors driving market growth. According to research report minimally invasive surgery device market is expected to grow from USD 20.1 billion in 2019 to USD 32.7 billion by 2025, at a CAGR of 8.5%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=682 By type of surgery, the cardiothoracic surgery segment accounted for the largest share of the global MIS instruments market in 2018. Based on type of surgery, the global minimally invasive surgery device market is divided into cardiothoracic surgery, gastrointestinal surgery, orthopedic surgery, gynecological surgery, cosmetic & bariatric surgery, urological surgery, and other surgeries. The cardiothoracic surgery segment accounted for the largest share of the global minimally invasive surgery device market in 20

The advantages of TFF over normal flow filtration (NFF), the increasing adoption of single-use technologies, and increased cGMP adoption are the key factors driving the market growth. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=72081607 According to the new market research report Tangential Flow Filtration Market is expected to grow from USD 944 million in 2019 to USD 1,590 million by 2024 at a CAGR of 11.0% during the forecast period. North America is projected to account for the largest share of the market in 2019 In 2019, North America is expected to account for the largest share of the Tangential Flow Filtration Market, followed by Europe. The largest share of the North American market is attributed to the presence of a well-established biopharmaceutical industry and significant R&D spending by pharmaceutical and biotechnology companies. An increasing focus on the enhancement of productivity and efficiency in biopharmaceutica

 According to research report the global contrast media market is expected to reach USD 6.0 billion by 2024 from an estimated USD 5.0 billion in 2019, growing at a CAGR of 3.8% during the forecast period. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=911 Growth in the contrast agent market can primarily be attributed to factors such as the increasing prevalence of cancer & CVD, regulatory approval of a growing number of contrast agents, and the rising volume of CT & MRI examinations. However, the side effects and allergic reactions associated with contrast agents are expected to limit market growth to a certain extent. North America to dominate the market in 2019 North America, Europe, Asia Pacific, and the Rest of the World (RoW) are the regions considered for geographic analysis of the global contrast agent market study. North America is expected to account for the largest share of the global contrast media industry. The large sha

  According to research report the lab informatics market is estimated to reach USD 3.8 billion by 2024 from USD 2.6 billion in 2019, at a CAGR of 7.5% during the forecast period. Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=203037633 Growth in the lab informatics market is mainly driven by the increasing need for laboratory automation, development of integrated lab informatics solutions, increasing need to comply with regulatory standards, and growing demand in biobanks/biorepositories. On the other hand, the lack of integration standards and high maintenance and service costs are expected to restrain the growth of this market to a certain extent. North America dominated the laboratory informatics solutions market in 2018. In 2018, North America dominated the market, followed by Europe. The large share of this market can primarily be attributed to the strong economies in the US and Canada, which have allowed for significant investments in

 According to research report the global X-Ray Detectors Market is projected to reach USD 3.8 billion by 2024 from USD 2.8 billion in 2019, at a CAGR of 6.1% during the forecast period. Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=7004984 Factors such as growing public and private investments in digital imaging technologies, declining prices and benefits offered by digital detectors, and reimbursement cuts for analog X-rays are driving the growth of the X-ray detector market. North America will continue to dominate the X-ray detectors market during the forecast period In 2019, North America is expected to account for the largest share of the X-ray detectors market. The large share of this region is attributed to factors such as technological innovations, increasing healthcare spending, availability of venture capital and government funding, and increasing incidence of chronic diseases. Europe is expected to account for the second-largest sh

  According to the new market research report Single use Bioreactors Market by Product (System, Media Bag, Filtration Assemblies), Type (Stirred tank, Bubble column), Type of Molecule (MAbs, Vaccine), Cell Type (Mammalian, Bacteria), Application (R&D), End User (CROs & CMOs) - Global Forecast to 2025, published by MarketsandMarkets™, the market is projected to reach USD 3.9 billion by 2025 from USD 1.7 billion in 2020, at a CAGR of 18.0% during the forecast period. Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=49113750 The Increasing adoption of SUBs among small companies and startups, reduced automation complexity, ease in the cultivation of marine organisms, reduced energy and water consumption, the growing biologics market, technological advancements in SUBs, and increasing Biopharmaceutical R&D are factors driving the growth of this market. Single-use bioreactor systems accounted for the largest share of Single-use Bio

  The growth of the market can be attributed to the initiatives by governments & NGOs to encourage organ donation, increasing investment in cell-based research, increasing prevalence of cardiovascular & respiratory diseases, and developments in biologics manufacturing. The high cost of organ transplantation and organ supply-demand gap, however, are expected to hinder the growth of the market. According to research report the Clinical Perfusion Systems Market is projected to reach USD 1,198.8 million by 2021 from USD 989.4 million in 2016, at a CAGR of 3.9% from 2016 to 2021. Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=164273069 North America is estimated to account for the largest share of the global Clinical Perfusion Systems Market, followed by Europe. The Asia-Pacific region is expected to witness the highest growth in the market during the forecast period. This growth will be particularly centered on China, Japan, and India. P

 According to research report the biopsy devices market is expected to reach USD 2.42 billion by 2022 from USD 1.74 billion in 2017, at a CAGR of 6.8% from 2017 to 2022. Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=132886515 Factors such as rising prevalence of cancer, increasing preference for minimally invasive surgeries, and initiatives undertaken by governments & global health organizations are the major factors driving the growth of this market. The Report analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America dominated the market in 2016 North America accounted for the largest share of the biopsy devices market in 2016, followed by Europe. The rising prevalence of cancer, government initiatives to spread awareness about cancer, favorable reimbursement scenario for biopsy devices in the U.S., and the presenc